The Competition Commission of Pakistan (CCP) has unleashed a fierce blow, seizing Rs. 150 million from Reckitt Benckiser Pakistan Limited for its outrageous and deceptive marketing of Strepsils. After the company’s appeal was brutally dismissed by the Competition Appellate Tribunal (CAT) for non-prosecution, the CCP wasted no time, invoking Section 40(2)(a) of the Competition Act, 2010, to freeze the company’s bank account and extract the full penalty.
Read More: CCP Slaps Rs. 42 Million Penalty on UDPL and IBL for Illegal Non‑Compete Pact
Reckitt Benckiser’s audacious scam involved peddling Strepsils as a medicated cure for sore throats, despite the product being stripped of its drug status after the company’s 2005 acquisition. For years, the corporation shamelessly pushed misleading ads, duping consumers and trampling the business interests of rival companies, blatantly violating Section 10 of the Competition Act, 2010.
The CCP’s investigation uncovered this flagrant deception, slapping Reckitt Benckiser with a Rs. 150 million fine. Undeterred, the company filed a weak appeal, only to have it crushed by the CAT. With no legal shield left, the CCP pounced, enforcing its ruling with ruthless efficiency.
This crackdown sends a chilling warning to corporate cheats: the CCP will not tolerate fraudulent practices that exploit consumers and undermine fair competition. Reckitt Benckiser’s reckless greed has cost it dearly—let this be a lesson to all!
